Research shows that stopping GLP-1 therapy often leads to regaining much of the lost weight, so ongoing, physician-led support is key for lasting results
Seek immediate medical attention if you experience unusual symptoms, including shortness of breath, swelling, or severe abdominal pain
doi:10.3389/fendo.2021.721135 20
Although most of the published studies suggest a modest beneficial effect, relatively few studies are well-controlled, the methods of assessment are not validated, and assessment may be insensitive to important changes induced by a variety of therapies, including L-carnitine itself
North America led the market in 2024 with over 50.14% share, generating around USD 5.4 Billion in revenue
Weakness: Physical weakness, particularly in the muscles and limbs